Estrogen receptor positive (ER+) subtype (Oestrogen receptor or hormone receptor subtype) is the most vital discriminator of breast cancer, accounting for nearly 75% of all breast cancer cases [10]. This evidence concerns the gene NR4A1 and breast cancer.